Immunic to participate in industry, scientific and investor conferences in november

New york , oct. 29, 2024 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry, scientific and investor conferences in november: november 4-6: bio-europe. members of immunic's management, business development and investor relations teams will participate in partnering activities at this conference in stockholm, sweden.
IMUX Ratings Summary
IMUX Quant Ranking